Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 760-766

  Şentürk, Tunay ^a   Çavun, Sinan ^a   Avci, Berrin ^a   Yermezler, Aysun ^a   Serdar, Zehra ^a   Savci, Vahide ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Apoptosis; M30 M65; Myocardium; N acetylcysteine; Oxidative stress; Reperfusion injury; Trimetazidine

Indexed keywords

ACETYLCYSTEINE; BIOLOGICAL MARKER; CASPASE 3; CYTOKERATIN 18; M65 PROTEIN; MALONALDEHYDE; PROTEIN S100B; SODIUM CHLORIDE; TRIMETAZIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORONARY RISK; EXPERIMENTAL MYOCARDIAL ISCHEMIA; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEFT CORONARY ARTERY; MALE; MONOTHERAPY; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; SERUM;

EID: 84910630607     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.091     Document Type: Article

References (30)

1. Braunwald E., Kloner R.A. Myocardial reperfusion: a double-edged sword?. J.Clin. Invest 1985, 76:1713-1719.
2. Yellon D.M., Haunsenloy D.J. Myocardial reperfusion injury. N.Engl. J. Med. 2007, 357:1121-1135.
3. Olivetti G., Quaini F., Sala R., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J.Mol. Cell. Cardiol. 1996, 28:2005-2016.
4. Kajstura J., Cheng W., Reiss K., et al. Apoptotic and necrotic cell death are independent contributing variables of infarct size in rats. Lab. Invest 1996, 74:86-107.
5. Palojoki E., Saraste A., Eriksson A., et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H2726-H2731.
6. Kantor P.F., Lucien A., Kozak R., Lopaschuk G.D. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial longchain 3-ketoacyl coenzyme A thiolase. Circ. Res. 2000, 86:580-588.
7. Parang P., Singh B., Arora R. Metabolic modulators for chronic cardiac ischemia. J.Cardiovasc Pharmacol. Ther. 2005, 10:217-223.
8. Drake-Holland A.J., Belcher P.R., Hynd J., Noble M.I. Infarct size in rabbits: a modified method illustrated by the effects of propranolol and trimetazidine. Basic Res. Cardiol. 1993, 88:250-258.
9. Noble M.I., Belcher P.R., Drake-Holland A.J. Limitation of infarct size by trimetazidine in the rabbit. Am. J. Cardiol. 1995, 76. 41B-4B.
10. Kurien V.A., Oliver M.F. Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion. Lancet 1966, 2:122-127.
11. Ceconi C., Curello S., Cargnoni A., et al. The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of Nacetyl cysteine. J.Mol. Cell. Cardiol. 1988, 20:5-13.
12. Arstall M.A., Yang J., Stafford I., et al. Nacetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation 1995, 92:2855-2862.
13. Chirkov Y.Y., Horowitz J.D. N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation. J.Cardiovasc Pharmacol. 1996, 28:375-380.
14. Scarabelli T., Stephanou A., Rayment N., et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 2001, 104(3):253-256.
15. McDouall R.M., Yacoub M., Rose M.L. Isolation, culture, and characterisation of MHC class II-positive microvascular endothelial cells from the human heart. Microvasc. Res. 1996, 51:137-152.
16. Adlbrecht C., Hoetzenecker K., Posch M., et al. Elevated levels of interleukin-1beta-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction. Eur. J. Clin. Invest 2007, 37:372-380.
17. Senturk T., Aydinlar A., Yilmaz Y., et al. changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease. Coron. Artery Dis. 2009, 20(8):494-498.
18. Tsoporis J.N., Marks A., Kahn H.J., et al. S100b inhibits beta 1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J.Biol. Chem. 1997, 272. 31915-31221.
19. Cai X.Y., Lu L., Wang Y.N., et al. Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury. Atherosclerosis 2011, 217:536-542.
20. Abe M., Takiguchi Y., Ichimaru S., et al. Comparison of the protective effect of N-acetylcysteine by different treatments on rat myocardial ischemia-reperfusion injury. J.Pharmacol. Sci. 2008, 106:571-577.
21. Argaud L., Gomez L., Gateau-Roesch O., et al. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia reperfusion injury. J.Mol. Cell. Cardiol. 2005, 39:893-899.
22. Ytrehus K., Liu Y., Tsuchida A., et al. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am. J. Physiol. 1994, 267:H2383-H2390.
23. Young I.S., Trimble E.R. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann. Clin. Biochem. 1991, 28:504-508.
24. Ruixing Y., Wenwu L., Al-Ghazeli R. Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion. Transl. Res. 2007, 149(3):152-160.
25. Forman M.B., Puett D.W., Cates C.U., et al. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. Circulation 1998, 78:202-213.
26. Yi X., Cui X., Wu P., et al. Effects of N-acetylcysteine on apoptosis induced by myocardial ischemia reperfusion injury in rats' heart transplantation. Za Zhi 2013, 27(10):1234-1239.
27. Wang J., Huang Y.W., Wei J.H., et al. Protective effect of trimetazidine on rabbit myocardium during ischemia- reperfusion. Zhejiang Da Xue Xue Bao Yi Xue Ban 2003, 32(3):219-222.
28. Oliver M.F., Kurien V.A., Greenwood T.W. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet 1968, 1:710-714.
29. Oliver M.F., Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994, 343:155-158.
30. Huttunen H.J., Kuja-Panula J., Sorci G., et al. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J.Biol. Chem. 2000, 275:40096-40105.